Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia
Status:
Unknown status
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the long-term safety and efficacy of Biogeneric
Epoetin, the attainability of therapeutic target for anaemia management, and the impact of
Epoetin treatment on long-term health outcome and its cost effectiveness.